Very long chain acyl-CoA dehydrogenase deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:26793OMIM:201475E71.3
Who is this for?
Show terms as
21Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Very long chain acyl-CoA dehydrogenase deficiency, commonly known as VLCAD deficiency or VLCADD, is a rare inherited metabolic disorder. It affects the body's ability to break down certain long-chain fatty acids — a type of fat found in food and stored in the body — and turn them into energy. This process normally happens in the mitochondria, which are the energy-producing parts of cells. When the ACADVL gene is not working properly, the enzyme responsible for this step is missing or not working well enough, causing fatty acids to build up and energy production to fall short, especially during times of fasting, illness, or physical exercise. The condition can affect the heart, muscles, and liver. Symptoms can range from mild to life-threatening and often first appear in infancy or early childhood, though some people are not diagnosed until adulthood. Common problems include low blood sugar (hypoglycemia), muscle pain and weakness, heart problems, and liver enlargement. Newborn screening programs in many countries now detect VLCAD deficiency at birth, which has greatly improved outcomes. Treatment focuses on preventing the body from running out of energy. This means avoiding long periods without eating, following a low-fat diet with medium-chain fat supplements, and managing illness carefully. With proper management, many people with VLCAD deficiency can live healthy, active lives. However, the condition requires lifelong attention and monitoring.

Also known as:

Key symptoms:

Low blood sugar (hypoglycemia), especially when fasting or sickMuscle pain, cramps, or weakness during or after exerciseExtreme tiredness or fatigueHeart muscle disease (cardiomyopathy), especially in infantsAbnormal heart rhythmsEnlarged liver (hepatomegaly)Breakdown of muscle tissue (rhabdomyolysis) triggered by exercise or illnessDark or cola-colored urine after muscle breakdown episodesNausea and vomiting during metabolic crisesIrritability or poor feeding in infantsLiver problems including elevated liver enzymesPeripheral neuropathy (nerve pain or numbness) in some adults

Clinical phenotype terms (40)— hover any for plain English
Increased circulating free fatty acid levelHP:0030781Patent foramen ovaleHP:0001655Hypoketotic hypoglycemiaHP:0001985HypothermiaHP:0002045Episodic tachypneaHP:0002876Exercise-induced rhabdomyolysisHP:0009045OverweightHP:0025502Anteriorly placed anusHP:0001545
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Very long chain acyl-CoA dehydrogenase deficiency.

View clinical trials →

No actively recruiting trials found for Very long chain acyl-CoA dehydrogenase deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Very long chain acyl-CoA dehydrogenase deficiency community →

Specialists

21 foundView all specialists →
GT
Go Tajima
Specialist
2 Very long chain acyl-CoA dehydrogenase deficiency publications
JL
John J Lefante
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
GN
Grace Noh
WALNUT, CA
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
JU
Jariya Upadia
NEW ORLEANS, LA
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
SC
Shiyan Cai
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
TD
Thomas Klopstock, Prof. Dr.
Specialist
PI on 3 active trials
JP
Jeroen AL Jeneson, PhD
Specialist
PI on 1 active trial
MD
Michelangelo Mancuso, Prof. Dr.
Specialist
PI on 1 active trial
JY
Junyi Yang
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
SA
Sara Abdulrahman Alkaff
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
MA
Meshari Fayez Aladhadh
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
SW
Shiyu Wang
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
HC
Hong Chen
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
WZ
Wenjing Zhao
CLEARWATER, FL
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
XZ
Xiaoyan Zhou
LANCASTER, CA
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
YZ
Yinhong Zhang
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
FA
Fahad Abdulrahman Algaeed
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication
SA
Suzan Suliman Alhumaidi
Specialist
1 Very long chain acyl-CoA dehydrogenase deficiency publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Very long chain acyl-CoA dehydrogenase deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Very long chain acyl-CoA dehydrogenase deficiencyForum →

No community posts yet. Be the first to share your experience with Very long chain acyl-CoA dehydrogenase deficiency.

Start the conversation →

Latest news about Very long chain acyl-CoA dehydrogenase deficiency

No recent news articles for Very long chain acyl-CoA dehydrogenase deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What are the specific fasting limits for my child's age, and how should we handle illness or surgery?,How much MCT oil should we use, and how do we incorporate it into meals?,Should my child take triheptanoin (Dojolvi), and would they qualify for it?,What are the signs of a metabolic crisis, and when should we go to the emergency room versus manage at home?,Does my child need regular heart monitoring, and how often should we check liver and muscle enzyme levels?,Are there any restrictions on physical activity, and how can we safely support exercise?,Should other family members be tested, and what are the chances of future children being affected?

Common questions about Very long chain acyl-CoA dehydrogenase deficiency

What is Very long chain acyl-CoA dehydrogenase deficiency?

Very long chain acyl-CoA dehydrogenase deficiency, commonly known as VLCAD deficiency or VLCADD, is a rare inherited metabolic disorder. It affects the body's ability to break down certain long-chain fatty acids — a type of fat found in food and stored in the body — and turn them into energy. This process normally happens in the mitochondria, which are the energy-producing parts of cells. When the ACADVL gene is not working properly, the enzyme responsible for this step is missing or not working well enough, causing fatty acids to build up and energy production to fall short, especially during

How is Very long chain acyl-CoA dehydrogenase deficiency inherited?

Very long chain acyl-CoA dehydrogenase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Very long chain acyl-CoA dehydrogenase deficiency?

21 specialists and care centers treating Very long chain acyl-CoA dehydrogenase deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.